The city of Monterey, California, currently has 2 active clinical trials seeking participants for Lymphoma research studies.
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
Recruiting
This study will evaluate the safety and efficacy of favezelimab (MK-4280) in combination with pembrolizumab (MK-3475) using a non-randomized study design in participants with the following hematological malignancies: classical Hodgkin lymphoma (cHL) diffuse large B-cell lymphoma (DLBCL) indolent non-Hodgkin lymphoma (iNHL) This study will also evaluate the safety and efficacy of pembrolizumab or favezelimab administered as monotherapy in participants with cHL using a 1:1 randomized study desig... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/24/2024
Locations: Pacific Cancer Care ( Site 0006), Monterey, California
Conditions: Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Recruiting
The Connect® Lymphoma Disease Registry is a US-based, multicenter, prospective observational (non-interventional) cohort study designed to collect real-world, participant-level data longitudinally in participants diagnosed with various subtypes of non-Hodgkin lymphoma (NHL).
Gender:
All
Ages:
18 years and above
Trial Updated:
11/15/2023
Locations: Pacific Cancer Care, Monterey, California
Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular